Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human/Mouse/Rat IGSF8/CD316 Antibody, R&D Systems™

Goat Polyclonal Antibody has been used in 5 publications
Supplier: R&D Systems AF3117
This item is not returnable.
View return policy
Description
IGSF8/CD316 Polyclonal specifically detects IGSF8/CD316 in Human, Mouse, Rat samples. It is validated for Western Blot, Simple Western, Flow Cytometry, Immunocytochemistry, CyTOF-ready.Specifications
IGSF8/CD316 | |
Polyclonal | |
Unconjugated | |
NP_536344 | |
IGSF8 | |
Mouse myeloma cell line NS0-derived recombinant mouse IGSF8/CD316 Ala25-Thr577 Accession # NP_536344 | |
100 μg | |
Primary | |
Detects mouse IGSF8/CD316 in direct ELISAs. Detects human and mouse IGSF8/CD316 in Western blots. In direct ELISAs, approximately 15% cross-reactivity with recombinant human IGSF8 is observed and less than 1% cross-reactivity with recombinant mouse IGSF4 is observed. | |
Human, Mouse | |
IgG |
Western Blot, Flow Cytometry, Immunocytochemistry, CyTOF | |
LYOPH | |
Western Blot 1 ug/mL, Flow Cytometry 0.25 ug/10^6 cells, Immunocytochemistry 5-15 ug/mL, CyTOF-ready | |
CD316, CD316 antigen, CD81P3, CD81P3LIR-D1, EWI2, EWI-2, EWI2CD81 partner 3, Glu-Trp-Ile EWI motif-containing protein 2, IgSF8, immunoglobulin superfamily, member 8, KCT4, KCT-4, Keratinocytes-associated transmembrane protein 4, PGRL, PGRLimmunoglobulin superfamily member 8 | |
Goat | |
Affinity Purified | |
RUO | |
93185 | |
Reconstitute at 0.2 mg/mL in sterile PBS. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction